Moreover, multiple CNAs recurrently featured in ATRX-deficient glioma mobilize established oncogenic and/or tumor suppressive loci, including MYC and CDKN2A2, implying that such structural abnormalities may contribute to the malignant evolution of this inexorably progressive cancer. This evidence concerns the gene MYC and glioma.